Industry News
Medical Device Industry News
Fictiv Adds 3D Visual Technology to Injection Molding Toolbox
The new feature reportedly can accelerate product development time by weeks or more.
FineHeart Awarded €2.5 Mil Grant by the EC Under the Highly Selective EIC Accelerator Program
FineHeart notes this grant has the potential to be followed by an equity investment of up to €15 million by the EIC Fund at the company’s next series C funding round. It will support the
Sol-Millennium Receives FDA Clearance for Sol-Guard Safety Pull Button Blood Collection Set
The Sol-Guard® Safety Pull Button Blood Collection Set features spring-activated needle retraction technology, designed to minimize the risk of accidental needlesticks and exposure to blood-borne pathogens.
Pleno Takes Another Step 'Beyond PCR' with VC Funding
The San Diego, CA-based company has raised $40 million in a series A round to continue the development of its Hypercoding Instrument Platform.
Alzheimer’s Diagnostic Test Spots Amyloid β Exosomes in Blood
Researchers at Hokkaido University in Japan have developed a biomarker test for Alzheimer’s disease that detects amyloid β binding exosomes in a blood sample. While amyloid β plaques in the brain are characteristic of Alzheimer’s,
How Functional Mushrooms Boost Your Heart Health
Functional mushrooms are widely recognized as foods that can help improve the immune system. They may also offer benefits that go beyond essential nourishment. They’re one of those superfoods that aid in promoting physical and
FEMSelect Secures US$9M Series B Financing
Debbie Garner, Co-CEO of FEMSelect, commented, "This investment is a testament to our team and the EnPlace® system. It enables us to expand the medical and patient communities and to serve many more women who
New Cardinal Health Research Highlights Rheumatologists’ Increasing Confidence in Biosimilars
The research revealed that rheumatologists are both more familiar with biosimilars and more comfortable prescribing them than they were in 2020, just in time for a wave of new biosimilars anticipated to hit the market
Slope Expands Go-To-Market Team for its eClinical Supply Chain Management Platform with Two Industry Veterans
Matt Smith joins Slope as Vice President, Research Site Development and Ben Carmel Joins as Chief Revenue Officer.
Medtronic Expands Global Access to the Benefits of Robotic-assisted Surgery
Hugo™ robotic-assisted surgery system approvals and indications set the stage for significant access across Europe, North America, and Asia — extending the benefits of minimally invasive surgery to new global audiences.
GI OnDEMAND Announces Partnership with Trellus Health
GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer access to the Trellus scientifically validated resilience training and self-management programs, to all GI OnDEMAND and ACG
Genetika+ Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment
NeuroKaire™ demonstrates high accuracy in predicting drug response in patients suffering from major depressive disorder.
Which Medicare Supplement Plan in the US Offers the Broadest Coverage?
It is a question that many seniors ask as they approach their 65th birthday and become eligible for Medicare. Many different plans are available, each with its own set of benefits. This article will take
Aerin Medical Announces Establishment of a New CPT® Code for Endoscopic Destruction of the Posterior Nasal Nerve Using Radiofrequency Ablation
“A new CPT code is an important milestone for ENT physicians and their patients, enabling appropriate valuation and improving access to this transformative solution that can be readily performed in the physician office setting,” said
SOTA’s Dental Imaging Software Gets Pearl’s AI Pathology Detection Capabilities
"Together with SOTA, we are pushing the envelope of dental imaging further toward a fully AI-powered dental future,” said Ophir Tanz, Pearl’s founder and CEO. “AI will be a basic utility in dentistry and we
Cordis Announces Acquisition of MedAlliance
By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.
A Drug-free Treatment for Migraines?
Study shows positive safety and efficacy data when using the Nerivio device.
Tivic Health to Acquire Assets of Reliefband
The company will expand its bioelectronic offerings with the Reliefband line of nausea and vomiting treatments.
Cordis Pumps Drug-Eluting Balloon Portfolio with M&A
The $1.135 billion deal would position Cordis as a market leader in drug-eluting balloon technology.
BioIntelliSense Adds AlertWatch to Remote Patient Monitoring Arsenal
Ann Arbor, MI-based AlertWatch develops and markets clinical decision support systems for hospitals.